Based on the equivalence theorem of a unitary optical system, we proposed an analytical approach to characterize the cell parameters of a twisted nematic liquid-crystal device (TNLCD) with full-field resolution. The spatial distribution of three characteristic parameters of a TNLCD was measured by using a polarizer-sample-analyzer imaging polarimeter so that the untwisted phase retardation, cell thickness, and twisted angle of a TNLCD can be directly calculated through the explicit expressions as a function of the characteristic parameters. The measured results agree well with the given values. This method can be implemented for characterization of a TNLCD in the manufacturing process.
In the measurement of a twisted nematic liquid crystal device (TNLCD) by an optical apparatus, the cell parameters of the TNLCD may result in multiple solutions in the measurement that all agree with the measured data; hence manufacturers cannot find a set of correct solutions from among the ambiguous ones. With the help of the optical equivalence theorem of a unitary optical system, the ambiguity of the measured parameters of a TNLCD, including cell parameters and equivalent birefringent parameters, can be simultaneously removed by an analytical approach using a single-wavelength polarimeter. The procedure for unique determination of the cell parameters is performed using a self-consistent condition to select a set of the correct solutions from all the possible solutions. The proposed method can be applied to characterize a generally TNLCD for which the twisted angle is close to 270° and the liquid crystal phase retardation is over 2π.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.